Jefferies Group’s Kyntra Bio KYNB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
– Sell
-772
Closed -$514K – 1808
2021
Q2
$514K Buy
+772
New +$445K ﹤0.01% 1159
2020
Q2
– Sell
-1,168
Closed -$1.02M – 1564
2020
Q1
$1.02M Hold
1,168
– – 0.01% 994
2019
Q4
$1.25M Buy
+1,168
New +$1.19M 0.01% 1332

Other funds holding KYNB

Jefferies Group's KYNB Position: Q3 2021 in Review

Jefferies Group sold out of Kyntra Bio (KYNB) in Q3 2021, closing a stake of 671 shares — an estimated $446K sold.

Jefferies Group first reported a position in KYNB in Q3 2019 and held it in 4 quarters. The position peaked at $679K in Q1 2020. 164 funds tracked by Wall St. Rank hold KYNB as of Q3 2021.

  • Jefferies Group reported no remaining Kyntra Bio position as of Q3 2021 after selling out during the quarter.
  • Jefferies Group sold 671 Kyntra Bio shares in Q3 2021, an estimated $446K.
  • Jefferies Group first reported a position in Kyntra Bio in Q3 2019 and held it in 4 quarters.
  • Jefferies Group's Kyntra Bio position peaked at $679K in Q1 2020.
  • 164 funds tracked by Wall St. Rank held Kyntra Bio as of Q3 2021.

Based on Jefferies Group's 13F filing for Q3 2021, filed 15 Nov 2021.